BRIEF-Transgene and Bristol-Myers Squibb announce clinical research collaboration

BRIEF-Transgene and Bristol-Myers Squibb announce clinical research collaboration


Bristol-Myers Squibb will provide Opdivo for use in study. Source text for Eikon: Further company coverage: WASHINGTON, April 25 The U.S. government's costs could increase by $2.3 billion in 2018 if Congress and President Donald Trump decide not to fund Obamacare-related payments to health insurers, according to a study released Tuesday by the Kaiser Family Foundation.



from Biotech News